Suppr超能文献

小儿心脏移植术后伴有心力衰竭的排斥反应。

Rejection with heart failure after pediatric cardiac transplantation.

作者信息

Flippin M J, Balzer D T, Murphy P R, Ruble S E, Mendeloff E N, Huddleston C B, Canter C E

机构信息

Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Ann Thorac Surg. 1999 Jul;68(1):176-80. doi: 10.1016/s0003-4975(99)00476-2.

Abstract

BACKGROUND

Rejection associated with heart failure or death occurs after pediatric cardiac transplantation but has had limited analysis.

METHODS

We analyzed the records of 96 consecutive pediatric cardiac transplant recipients who survived to hospital discharge.

RESULTS

Eighteen patients (19%) experienced 23 episodes of heart failure or death associated with rejection. Univariate analysis demonstrated black race (p = 0.041), transplantation after 12 months of age (p = 0.032), later time after transplantation (p = 0.037), rejection episode in the first year after transplantation (p = 0.001), and history of two or more rejection episodes (p < 0.001) were significantly associated with rejection seen with heart failure. A multivariate regression analysis identified two or more rejection episodes to be the only independent risk factor for the development of rejection with heart failure (odds ratio 20; 95% confidence limits, 4-104; p < 0.0001).

CONCLUSIONS

This study identified pediatric heart transplant recipients with a history of previous rejection episodes to be at a higher risk for symptomatic or fatal rejection. Further studies are needed to determine if intensification of maintenance immunosuppression, long-term rejection surveillance, or both in patients with multiple rejection episodes could reduce morbidity and mortality from rejection.

摘要

背景

小儿心脏移植术后会发生与心力衰竭或死亡相关的排斥反应,但对此的分析有限。

方法

我们分析了96例连续存活至出院的小儿心脏移植受者的记录。

结果

18例患者(19%)发生了23次与排斥反应相关的心力衰竭或死亡事件。单因素分析显示,黑人种族(p = 0.041)、12个月龄后进行移植(p = 0.032)、移植后时间较晚(p = 0.037)、移植后第一年发生排斥反应(p = 0.001)以及有两次或更多次排斥反应病史(p < 0.001)与心力衰竭相关的排斥反应显著相关。多因素回归分析确定两次或更多次排斥反应是发生与心力衰竭相关的排斥反应的唯一独立危险因素(比值比20;95%置信区间,4 - 104;p < 0.0001)。

结论

本研究发现有既往排斥反应病史的小儿心脏移植受者发生有症状或致命性排斥反应的风险更高。需要进一步研究以确定对于有多次排斥反应病史的患者,强化维持免疫抑制、长期排斥反应监测或两者同时进行是否能降低排斥反应导致的发病率和死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验